Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases

Category Primary study
JournalJournal of Immunotherapy and Precision Oncology
Year 2024
This article has no abstract
Epistemonikos ID: 57727ede33c6b169746b421c09a5dc14f63928de
First added on: Feb 19, 2025